Skip to main content
Top
Published in: Reactions Weekly 1/2015

01-04-2015 | Case report

Streptokinase/tenecteplase

Bleeding complications: 3 case reports

Published in: Reactions Weekly | Issue 1/2015

Login to get access

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literature
go back to reference Chau HW, et al. Efficacy and safety of tenectaplase versus streptokinase in treating st-elevation myocardial infarction patients in Hong Kong: A four-year retrospective review in Queen Elizabeth Hospital. Hong Kong Journal of Emergency Medicine 20: 359-363, No. 6, Jan 2013 - Hong Kong Chau HW, et al. Efficacy and safety of tenectaplase versus streptokinase in treating st-elevation myocardial infarction patients in Hong Kong: A four-year retrospective review in Queen Elizabeth Hospital. Hong Kong Journal of Emergency Medicine 20: 359-363, No. 6, Jan 2013 - Hong Kong
Metadata
Title
Streptokinase/tenecteplase
Bleeding complications: 3 case reports
Publication date
01-04-2015
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2015
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-015-9316-7

Other articles of this Issue 1/2015

Reactions Weekly 1/2015 Go to the issue

Case report

Trastuzumab

Case report

Diclofenac

Case report

Rituximab